Stock Comparison
PMCB vs AAPL
Side-by-side fundamentals, quality, value, and price momentum analysis.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Metrics Comparison
Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.
PMCB vs AAPL: Key Questions Answered
Which is the cheapest stock: PMCB or AAPL?
Based on P/E ratio, PharmaCyte Biotech, Inc. (PMCB) is the cheapest at 0.3x earnings. Apple Inc. (AAPL) is the most expensive at 34.6x. A lower P/E can indicate better value, but always consider growth rates too.
Which stock is growing the fastest: PMCB or AAPL?
Apple Inc. (AAPL) is growing the fastest with 6.4% revenue growth. PharmaCyte Biotech, Inc. has the slowest growth at 0.0%. Higher growth often justifies higher valuations.
Which has the best profit margins: PMCB or AAPL?
Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. PharmaCyte Biotech, Inc. has the lowest at 0.0%. Higher margins indicate pricing power and efficiency.
Which pays the highest dividend: PMCB or AAPL?
PharmaCyte Biotech, Inc. (PMCB) offers the highest dividend yield of 16.5%. Apple Inc. has the lowest at 0.4%. For income investors, higher yield matters, but check payout sustainability.
Which is the largest company: PMCB or AAPL?
Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. PharmaCyte Biotech, Inc. is the smallest at $0.0B. Larger companies tend to be more stable but may have less growth potential.
Which stock has the best return on equity: PMCB or AAPL?
Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. PharmaCyte Biotech, Inc. has the lowest at 67.1%. Higher ROE indicates efficient use of capital.